Soluble MUC1 inhibits adhesion of MUC1-expressing cells to ICAM-1 suggesting an immunosupressive role for the MUC1 shed into the tumor microenvironment and the high levels of circulating mucin often found in advanced stage disease [104]. Here, ICAM1 is linked to neoplasm.